<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Cardiovasc Dev Dis</journal-id><journal-id journal-id-type="iso-abbrev">J Cardiovasc Dev Dis</journal-id><journal-id journal-id-type="publisher-id">jcdd</journal-id><journal-title-group><journal-title>Journal of Cardiovascular Development and Disease</journal-title></journal-title-group><issn pub-type="epub">2308-3425</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6162525</article-id><article-id pub-id-type="doi">10.3390/jcdd5030048</article-id><article-id pub-id-type="publisher-id">jcdd-05-00048</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="0" pm="."><plain>Analysis of Angiotensin Converting Enzyme, Endothelial Nitric Oxide Synthase &amp; Serotonin Gene Polymorphisms among Atrial Septal Defect Subjects with and without Pulmonary Arterial Hypertension </plain></SENT>
</text></SecTag></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Jaafar</surname><given-names>Nur Ilyana</given-names></name><xref ref-type="aff" rid="af1-jcdd-05-00048">1</xref></contrib><contrib contrib-type="author"><name><surname>Vasudevan</surname><given-names>Ramachandran</given-names></name><xref ref-type="aff" rid="af2-jcdd-05-00048">2</xref><xref rid="c1-jcdd-05-00048" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Ismail</surname><given-names>Patimah</given-names></name><xref ref-type="aff" rid="af1-jcdd-05-00048">1</xref><xref rid="c1-jcdd-05-00048" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Abdul Aziz</surname><given-names>Ahmad Fazli</given-names></name><xref ref-type="aff" rid="af3-jcdd-05-00048">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-9015-0525</contrib-id><name><surname>Mohamad</surname><given-names>Nur Afiqah</given-names></name><xref ref-type="aff" rid="af2-jcdd-05-00048">2</xref></contrib><contrib contrib-type="author"><name><surname>Kandavello</surname><given-names>Geetha</given-names></name><xref ref-type="aff" rid="af4-jcdd-05-00048">4</xref></contrib><contrib contrib-type="author"><name><surname>Raja Adnan</surname><given-names>Raja Nurzatul Effah</given-names></name><xref ref-type="aff" rid="af2-jcdd-05-00048">2</xref></contrib><contrib contrib-type="author"><name><surname>Balasubramaniam</surname><given-names>Vinod</given-names></name><xref ref-type="aff" rid="af5-jcdd-05-00048">5</xref></contrib></contrib-group><aff id="af1-jcdd-05-00048"><label>1</label>Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang 43400, Malaysia; <email>elle.ilyana@gmail.com</email></aff><aff id="af2-jcdd-05-00048"><label>2</label>Malaysian Research Institute on Ageing, Universiti Putra Malaysia, Serdang 43400, Malaysia; <email>nur_iqa87@yahoo.com</email> (N.A.M.); <email>r_zatulefa@upm.edu.my</email> (R.N.E.R.A.)</aff><aff id="af3-jcdd-05-00048"><label>3</label>Department of Medicine, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang 43400, Malaysia; <email>afazli@upm.edu.my</email></aff><aff id="af4-jcdd-05-00048"><label>4</label>Department of Pediatric Clinic, National Heart Institute, Jalan Tun Razak, Kuala Lumpur 50400, Malaysia; <email>geetha@ijn.com.my</email></aff><aff id="af5-jcdd-05-00048"><label>5</label>Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway 47500, Malaysia; <email>vinod.balasubramaniam@monash.edu</email></aff><author-notes><corresp id="c1-jcdd-05-00048"><label>*</label>Correspondence: <email>vasuphd@gmail.com</email> (R.V.); <email>patimah@upm.edu.my</email> (P.I.); Tel.: +60-7-254-6430 (R.V.); +60-10-205-5338 (P.I.)</corresp></author-notes><pub-date pub-type="epub"><day>18</day><month>9</month><year>2018</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2018</year></pub-date><volume>5</volume><issue>3</issue><elocation-id>48</elocation-id><history><date date-type="received"><day>10</day><month>7</month><year>2018</year></date><date date-type="accepted"><day>17</day><month>9</month><year>2018</year></date></history><permissions><copyright-statement>© 2018 by the authors.</copyright-statement><copyright-year>2018</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p><SecTag type="ABS"><text><SENT sid="1" pm="."><plain>Genetic polymorphisms are variations in DNA sequences which can influence either disease susceptibility, severity, or prognosis. </plain></SENT>
<SENT sid="2" pm="."><plain>Pulmonary arterial hypertension (PAH) is one of the complications that occurs in certain patients who have atrial septal defect (ASD). </plain></SENT>
<SENT sid="3" pm="."><plain>This study seeks to determine the association of gene polymorphisms with the pathogenesis of PAH in ASD patients. </plain></SENT>
<SENT sid="4" pm="."><plain>This study was conducted on 30 ASD patients with PAH, and 50 ASD patients who were not diagnosed with PAH. </plain></SENT>
<SENT sid="5" pm="."><plain>All respondents were Malay. </plain></SENT>
<SENT sid="6" pm="."><plain>Patients were selected based on stringent inclusion and exclusion criteria. </plain></SENT>
<SENT sid="7" pm="."><plain>Molecular analyses were done to detect the genetic polymorphisms of angiotensin converting enzyme (ACE I/D), serotonin transporter (5-HTTLPR), endothelial nitric oxide synthase (eNOS) G894T, and eNOS 4b/4a. </plain></SENT>
<SENT sid="8" pm="."><plain>The genotypes of these genetic polymorphisms were determined using conventional PCR and PCR-RFLP methods. </plain></SENT>
<SENT sid="9" pm="."><plain>The PCR products were analysed using agarose gel electrophoresis. </plain></SENT>
<SENT sid="10" pm="."><plain>Statistical analysis was done using SPSS Version 22. </plain></SENT>
<SENT sid="11" pm="."><plain>Clinical characteristics, such as the diameter of ASD, mean arterial pressure (MAP), and mean pulmonary artery pressure (mPAP) differed significantly (p &lt; 0.05). </plain></SENT>
<SENT sid="12" pm="."><plain>Based on the statistical analysis, ACE I/D, eNOS G894T, and eNOS 4b/4a do not contribute to the progression of PAH amongst ASD patients (p &gt; 0.05). </plain></SENT>
<SENT sid="13" pm="."><plain>However, the L allele of the 5-HTTLPR gene polymorphism may have an affect on the development of PAH in ASD patients (p &lt; 0.05). </plain></SENT>
</text></SecTag></p></abstract><SecTag type="KEYWORD"><kwd-group><kwd>pulmonary artery hypertension</kwd><kwd>atrial septal defect</kwd><kwd>genetic polymorphisms</kwd></kwd-group></SecTag></article-meta></front><body><SecTag type="INTRO"><sec id="sec1-jcdd-05-00048"><title><text><SENT sid="14" pm="."><plain>1. </plain></SENT>
<SENT sid="15" pm="."><plain>Introduction </plain></SENT>
</text></title><p><text><SENT sid="16" pm="."><plain>Atrial septal defect (ASD) is a congenital heart defect caused by the presence of an interatrial communication. </plain></SENT>
<SENT sid="17" pm="."><plain>ASD is usually asymptomatic in children, but in adults, it may be complicated by pulmonary arterial hypertension (PAH). </plain></SENT>
<SENT sid="18" pm="."><plain>Since PAH patients do not show obvious symptoms at the early stage, there may be delayed diagnosis and treatment [1]. </plain></SENT>
<SENT sid="19" pm="."><plain>PAH, a disease that affects small pulmonary arteries, is characterised by an increase in the pressure of pulmonary artery and pulmonary vessels’ resistance, which can lead to death due to right ventricular failure [2]. </plain></SENT>
<SENT sid="20" pm="."><plain>The normal blood pressure of a pulmonary artery at rest is usually around 8 mmHg to 20 mmHg, but in pulmonary arterial hypertensive individuals, the mean pulmonary arterial pressure at rest is &gt;25 mmHg with normal pulmonary capillary wedge pressure [3]. </plain></SENT>
<SENT sid="21" pm="."><plain>In most cases, ASD causes left-to-right shunts [4]. </plain></SENT>
<SENT sid="22" pm="."><plain>The direction and magnitude of the shunting strongly depends on the size of the defect and the relative compliance of the left and right that can change over time [2]. </plain></SENT>
<SENT sid="23" pm="."><plain>The incidence of PAH is around 2 cases per a million population per year, and can affect individuals at any age, but is most common among adults between 36 to 50 years of age [1]. </plain></SENT>
<SENT sid="24" pm="."><plain>Patients with ASD are usually asymptomatic and tend to develop PAH after turning 30. </plain></SENT>
<SENT sid="25" pm="."><plain>However, in some patients, the onset of PAH is noted earlier, and even in small ASD with insignificant left to right shunts. </plain></SENT>
<SENT sid="26" pm="."><plain>The reason remains unclear. </plain></SENT>
<SENT sid="27" pm="."><plain>It is believed that in this group of patients, the pathophysiology of PAH is more similar to those with idiopathic PAH. </plain></SENT>
</text></p><p><text><SENT sid="28" pm="."><plain>There are several genes being hypothesised to be involved in PAH, such as serotonin (5-HT), endothelial nitric oxide synthase (eNOS), and angiotensin converting enzyme (ACE I/D) [5,6]. </plain></SENT>
<SENT sid="29" pm="."><plain>A conducted meta-analysis showed a significant association between serotonin transporter (SERT) polymorphism with idiopathic pulmonary hypertension [7], but there is a lack of study on SERT polymorphism with PAH in ASD. </plain></SENT>
<SENT sid="30" pm="."><plain>A functional gene polymorphism has been identified at the promoter region of the 5-HT gene, a 44 bp insertion/deletion polymorphism (5-HTTLPR) [8]. </plain></SENT>
<SENT sid="31" pm="."><plain>A study in pediatric patients of idiopathic PAH shows the presence of homozygous L genotype in 90% of the patients, suggesting the role of 5-HTT in the development of pulmonary hypertension both in children and adults [9]. </plain></SENT>
</text></p><p><text><SENT sid="32" pm="."><plain>Nitric oxide synthase is one of the candidate genes involved in PAH. </plain></SENT>
<SENT sid="33" pm="."><plain>The NOS3 or eNOS gene that encodes eNOS is expressed by vascular endothelial cells. </plain></SENT>
<SENT sid="34" pm="."><plain>Variations in the gene will alter nitric oxide (NO) synthesis. </plain></SENT>
<SENT sid="35" pm="."><plain>Polymorphisms of the eNOS gene have been studied in several populations in relation to IPAH [10,11] and cardiovascular disorders [12]. </plain></SENT>
</text></p><p><text><SENT sid="36" pm="."><plain>The role of ACE insertion/deletion (I/D) polymorphism on the development of PAH will be investigated in this study as well. </plain></SENT>
<SENT sid="37" pm="."><plain>The ACE gene, a major component in renin angiotensin aldosterone system, has been implicated in the pathogenesis of cardiovascular disease [13] and essential hypertension [14]. </plain></SENT>
<SENT sid="38" pm="."><plain>I/D polymorphism of ACE gene is one of the most common polymorphisms being studied [15,16]. </plain></SENT>
<SENT sid="39" pm="."><plain>The risk of developing coronary artery disease, myocardial infarction, or left ventricular hypertrophy increase with the presence of the ACE DD genotype [17,18]. </plain></SENT>
<SENT sid="40" pm="."><plain>Therefore, it has been postulated that the ACE genotype plays a role in PAH progression by modulating the expression of the ACE gene [19]. </plain></SENT>
</text></p><p><text><SENT sid="41" pm="."><plain>Since genetic diversity exists among different ethnic populations, and taking into account the fact that the association in one population could not be extrapolated to another, this study only involves Malay patients. </plain></SENT>
<SENT sid="42" pm="."><plain>In Malaysia, there is lack of data on the association between genetic polymorphisms with PAH and ASD. </plain></SENT>
<SENT sid="43" pm="."><plain>This stimulated us to study genetic polymorphisms in relation to the early progression of PAH associated with ASD. </plain></SENT>
</text></p></sec></SecTag><SecTag type="METHODS"><sec id="sec2-jcdd-05-00048"><title><text><SENT sid="44" pm="."><plain>2. </plain></SENT>
<SENT sid="45" pm="."><plain>Materials and Methods </plain></SENT>
</text></title><p><text><SENT sid="46" pm="."><plain>This study comprises of 30 ASD subjects with pulmonary arterial hypertension (cases), and 50 ASD subjects without pulmonary arterial hypertension (controls). </plain></SENT>
<SENT sid="47" pm="."><plain>The subjects were recruited from the Pediatric Clinic of the National Heart Institute. </plain></SENT>
<SENT sid="48" pm="."><plain>Sample size was calculated by aiming at 80% statistical power. </plain></SENT>
<SENT sid="49" pm="."><plain>Prior to recruiting the subjects, ethical approval was obtained from the Ethic Institutional Review Board of Universiti Putra Malaysia (UPM) and the Ethics Committee of the National Heart Institute. </plain></SENT>
<SENT sid="50" pm="."><plain>The work was carried out in accordance with The Code of Ethics of The World Medical Association (Declaration of Helsinki) for experiments on humans. </plain></SENT>
<SENT sid="51" pm="."><plain>Consent was obtained from all subjects before recruiting them, and the socio-demographic and medical history of each subject was recorded. </plain></SENT>
<SENT sid="52" pm="."><plain>Subjects were diagnosed with established PAH by right heart catherisation and with secundum Atrial Septal Defect, with no other cardiac anomaly. </plain></SENT>
<SENT sid="53" pm="."><plain>The next criteria are subjects with mean pulmonary arterial pressure &gt;50% mean systemic pressure, and mean pulmonary capillary wedge pressure &lt;2 kPa (15 mmHg). </plain></SENT>
<SENT sid="54" pm="."><plain>Patients who are genotypically diagnosed with Down Syndrome with abnormally accelerated PAH or PAH related to other etiologies and patients suffering from other than secundum ASD were excluded from the study. </plain></SENT>
</text></p><sec id="sec2dot1-jcdd-05-00048"><title><text><SENT sid="55" pm="."><plain>2.1. </plain></SENT>
<SENT sid="56" pm="."><plain>Genetic Analysis </plain></SENT>
</text></title><p><text><SENT sid="57" pm="."><plain>A total of 4 mL of blood was collected from subjects’ peripheral blood leukocytes into an EDTA tube (Becton Dickinson, East Rutherford, NJ, USA) by a qualified phlebotomist. </plain></SENT>
<SENT sid="58" pm="."><plain>Plasma was separated from the blood by centrifugation and stored at −20 °C for further analysis. </plain></SENT>
<SENT sid="59" pm="."><plain>Genomic DNA from peripheral blood was isolated by using the QIAamp Blood DNA Mini Kit (QIAGEN, Hilden, Germany). </plain></SENT>
<SENT sid="60" pm="."><plain>The purity of extracted DNA was checked by using a Biophotometer (Eppendorf, Hamburg, Germany). </plain></SENT>
<SENT sid="61" pm="."><plain>Each gene polymorphism underwent PCR by using their respective primers and specific reaction conditions (Table 1). </plain></SENT>
</text></p><p><text><SENT sid="62" pm="."><plain>The PCR reactions were done by using a G-Storm GS1 Thermal Cyclers (Somertone Biotechnology Center, Somerset, UK). </plain></SENT>
<SENT sid="63" pm="."><plain>The PCR products were then kept at −20 °C for further analysis. </plain></SENT>
<SENT sid="64" pm="."><plain>The PCR products were determined by using agarose gel electrophoresis, and visualised under UV light. </plain></SENT>
<SENT sid="65" pm="."><plain>The results were validated by choosing 20% of samples at random, and a similar analysis was again carried out to confirm the genotyping results. </plain></SENT>
<SENT sid="66" pm="."><plain>Identical results were obtained when the genotyping was performed on two separate occasions. </plain></SENT>
</text></p></sec><sec id="sec2dot2-jcdd-05-00048"><title><text><SENT sid="67" pm="."><plain>2.2. </plain></SENT>
<SENT sid="68" pm="."><plain>Statistical Analysis </plain></SENT>
</text></title><p><text><SENT sid="69" pm="."><plain>Clinical characteristics of all the subjects were expressed as mean ± SD. </plain></SENT>
<SENT sid="70" pm="."><plain>The student’s t-test and chi-square test were used to analyse the variables. </plain></SENT>
<SENT sid="71" pm="."><plain>The frequencies of alleles were estimated by using the allele counting method and Hardy-Weinberg equilibrium assessment. </plain></SENT>
<SENT sid="72" pm="."><plain>A one-way ANOVA test was used to compare the group means. </plain></SENT>
<SENT sid="73" pm="."><plain>All statistical analyses were performed by using SPSS version 21.0 (SPSS Inc., Chicago, IL, USA); p &lt; 0.05 was considered to be statistically significant. </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="RESULTS"><sec id="sec3-jcdd-05-00048"><title><text><SENT sid="74" pm="."><plain>3. </plain></SENT>
<SENT sid="75" pm="."><plain>Results </plain></SENT>
</text></title><p><text><SENT sid="76" pm="."><plain>In this study, 80 ASD patients of Malay ethnicity were sampled. </plain></SENT>
<SENT sid="77" pm="."><plain>The control group, which are ASD patients without PAH, comprised of 50 (62.5%) samples, whereas 30 (37.5%) were ASD patients with PAH. </plain></SENT>
<SENT sid="78" pm="."><plain>A majority of the ASD patients with PAH were female (93.3%). </plain></SENT>
<SENT sid="79" pm="."><plain>Whereas for those diagnosed with ASD without PAH, 88% were females. Table 2 tabulates the clinical characteristics of subjects in both groups with respect to age, age at diagnosis, size of ASD, mean arterial pressure (MAP), and mPAP with p &lt; 0.05. </plain></SENT>
</text></p><p><text><SENT sid="80" pm="."><plain>The mean age for the control subjects was higher than that of the case subjects. </plain></SENT>
<SENT sid="81" pm="."><plain>There was no significant difference observed for age and age patients diagnosed with ASD. </plain></SENT>
<SENT sid="82" pm="."><plain>However, patients with PAH were diagnosed to have ASD earlier than ASD patients who had not developed PAH. </plain></SENT>
<SENT sid="83" pm="."><plain>There was a significant difference found in the diameter of defects, MAP and mPAP. </plain></SENT>
<SENT sid="84" pm="."><plain>The size of ASD was found to be bigger in patients with PAH. Figure 1 shows the PCR products of each gene polymorphism, and Table 3 demonstrates the genotypic and allelic distributions of ACE I/D, G894T and 4b/4a gene polymorphism of the eNOS gene and the 5-HTTLPR gene polymorphism of the PAH and non-PAH groups. </plain></SENT>
</text></p><p><text><SENT sid="85" pm="."><plain>There was no significant association found between the ACE I/D and both eNOS G894T and eNOS 4b/4a gene polymorphisms with the ASD subjects (p &lt; 0.05). </plain></SENT>
<SENT sid="86" pm="."><plain>However, there is an association between the L allele of 5-HTTLPR gene polymorphism with PAH among ASD patients (p &lt; 0.05). </plain></SENT>
<SENT sid="87" pm="."><plain>A multivariate test (General Linear Model) was performed to identify the confounding factor for all the genetic polymorphisms, to compare the associations between genotypes and clinical parameters (Table 4). </plain></SENT>
<SENT sid="88" pm="."><plain>In this study, the clinical parameters analysed are age, diameter of defects, MAP, and mPAP. </plain></SENT>
<SENT sid="89" pm="."><plain>There were no significant differences found between the genotypes of all the gene polymorphisms of the genes studied and the risk factors in both groups. </plain></SENT>
</text></p></sec></SecTag><SecTag type="DISCUSS"><sec id="sec4-jcdd-05-00048"><title><text><SENT sid="90" pm="."><plain>4. </plain></SENT>
<SENT sid="91" pm="."><plain>Discussion </plain></SENT>
</text></title><p><text><SENT sid="92" pm="."><plain>This study aims to identify the differences between ASD patients without PAH and ASD patients with PAH in terms of genetic makeup, as this may help us have more understanding on the pathophysiology of the disease. </plain></SENT>
<SENT sid="93" pm="."><plain>Candidate gene analysis enables the identification of the presence of known gene variations of candidate genes (ACE, eNOS and 5-HTTLPR) that may be implicated in the pathogenesis of PAH. </plain></SENT>
<SENT sid="94" pm="."><plain>Thus, a genotype-phenotype association can be determined, and patients can then be classified into the high-risk group that may develop PAH, so that early therapeutic and preventive measures can be implemented. </plain></SENT>
<SENT sid="95" pm="."><plain>The findings from this study might give some new insight into the management of ASD patients. </plain></SENT>
</text></p><p><text><SENT sid="96" pm="."><plain>A higher percentage of LL genotypes of 5-HTTLPR with gene polymorphism was noticed in the PAH group. </plain></SENT>
<SENT sid="97" pm="."><plain>Our findings support the 5-HTT pathway in causing pulmonary vascular remodeling and PAH development by the overexpression of 5-HTT [20,21]. </plain></SENT>
<SENT sid="98" pm="."><plain>Patients with LL genotypes will express more than double the serotonin mRNA in the pulmonary artery muscle cells [22]. </plain></SENT>
<SENT sid="99" pm="."><plain>In this present study, we found that the L allele of the 5-HTTLPR gene polymorphism was associated with an increased risk of possible PAH. </plain></SENT>
<SENT sid="100" pm="."><plain>To the best of our knowledge, this is the first molecular study on our population that investigates the association of the 5-HTTLPR gene polymorphism with PAH in Malay ASD patients. </plain></SENT>
<SENT sid="101" pm="."><plain>It is in correspondence with studies by Eddahibi et al. (2001) [20] and Willers et al. (2006) [22], which suggested an association between the LL genotype and the risk of developing PH. </plain></SENT>
<SENT sid="102" pm="."><plain>Although statistical differences were not reached, higher mPAP was observed for the LL genotypes in the PAH group. </plain></SENT>
<SENT sid="103" pm="."><plain>These findings are in accordance with another study conducted on Spanish [22], Caucasian [23] and Turkish [24] subjects. </plain></SENT>
<SENT sid="104" pm="."><plain>Other than that, the diameter of defects were found to be larger for the SS and LS genotypes, but the mPAP was higher for the LL genotypes in the PAH group. </plain></SENT>
<SENT sid="105" pm="."><plain>It is suggested that patients who carry the LL genotype are more severe than those who carry the SS or LS genotype, despite the size of the defect, due to the higher level of mPAP in the LL group. </plain></SENT>
<SENT sid="106" pm="."><plain>Homozygous L alleles cause the double expression of serotonin in the primary pulmonary artery smooth muscle cells. </plain></SENT>
<SENT sid="107" pm="."><plain>This in turn leads to vascular smooth muscle hyperplasia and vascular remodeling, that cause an increase in the pulmonary artery pressure [20]. </plain></SENT>
</text></p><p><text><SENT sid="108" pm="."><plain>The deletion polymorphism of the ACE gene has been known to cause an increase in angiotensin II, and renin angiotensin system is involved in pulmonary artery remodeling [25]. </plain></SENT>
<SENT sid="109" pm="."><plain>However, different studies on the ACE DD genotype effect on cardiovascular diseases have produced different results [24,26]. </plain></SENT>
<SENT sid="110" pm="."><plain>Since there was no significant difference found in the ACE genotype distribution and allele frequencies among groups, it can be concluded that ACE gene polymorphisms may not be the risk factor in the development of PAH among Malay ASD patients. </plain></SENT>
<SENT sid="111" pm="."><plain>The result was similar to a study by Hoeper et al. (2003), in which there were no significant differences in mPAP between cases and control subjects with II, ID or DD genotypes [27]. </plain></SENT>
</text></p><p><text><SENT sid="112" pm="."><plain>A greater percentage of the G allele of eNOS G894T polymorphism in the non-PAH group (70.65%), rather that in the PAH patients (48.4%), was also observed in Toganel’s study [28]. </plain></SENT>
<SENT sid="113" pm="."><plain>In the present study, the incidence of G allele was almost similar between the control group (49%) and the AHD cases (48.33%). </plain></SENT>
<SENT sid="114" pm="."><plain>Another study by Vadapalli et al. (2010) [10] also showed that no significant difference was observed between idiopathic PAH and the control group. </plain></SENT>
<SENT sid="115" pm="."><plain>It is assumed that maybe there are gene-gene and gene-environment interactions that play a role in the function of eNOS G894T polymorphism regarding the pathogenesis of PAH in Malays. </plain></SENT>
</text></p><p><text><SENT sid="116" pm="."><plain>In this present study, we found no association between the eNOS 4b/4a polymorphism and PAH in Malay ASD patients. </plain></SENT>
<SENT sid="117" pm="."><plain>The frequency of the “a” allele was higher in patients with PAH (23.33%) as compared to those with ASD (20%). </plain></SENT>
<SENT sid="118" pm="."><plain>However, these findings do not support past literature, which correlated a lower detection of NO metabolites with the presence of the “a” allele [29]. </plain></SENT>
<SENT sid="119" pm="."><plain>A higher percentage of the “b” allele was observed among the non-PAH group. </plain></SENT>
<SENT sid="120" pm="."><plain>This may suggest a protective effect of the “b” allele against PAH. </plain></SENT>
<SENT sid="121" pm="."><plain>Another study in Romania [28] on PAH among children with congenital heart diseases also gave negative results. </plain></SENT>
<SENT sid="122" pm="."><plain>The eNOS 4b/4a was also found to have no association with PH in COPD patients in both Turkish and Zurich populations [10,24]. </plain></SENT>
</text></p><p><text><SENT sid="123" pm="."><plain>Table 5 summarises the genotypic and allelic distributions of all the gene polymorphisms of the genes studied on several types of PAH in other populations, with contradictory results. </plain></SENT>
<SENT sid="124" pm="."><plain>This can be due to confounding factors, such as different ethnicities, or different environment backgrounds which have influences on the genetic makeup. </plain></SENT>
</text></p><p><text><SENT sid="125" pm="."><plain>The present study has some limitations. </plain></SENT>
<SENT sid="126" pm="."><plain>Although our study sample was relatively small as compared to other epidemiological and association studies, the result of this study supports the hypothesis that the L allele of the 5-HTTLPR gene has an association with PAH in ASD subjects. </plain></SENT>
<SENT sid="127" pm="."><plain>A more extensive study can be done in future with a larger sample size and more stringent inclusion and exclusion criteria to further confirm the hypothesis, and to confirm the association between the gene polymorphism of the ACE, eNOS, and 5-HTTLPR genes. </plain></SENT>
<SENT sid="128" pm="."><plain>Further investigation is needed to understand the possible role of other polymorphisms of various genes in relation to ASD among the three ethnic races in Malaysia. </plain></SENT>
</text></p></sec></SecTag><SecTag type="CONCL"><sec id="sec5-jcdd-05-00048"><title><text><SENT sid="129" pm="."><plain>5. </plain></SENT>
<SENT sid="130" pm="."><plain>Conclusions </plain></SENT>
</text></title><p><text><SENT sid="131" pm="."><plain>Among all the gene polymorphisms studied in this study, the 5-HTTLPR (rs25531) can be considered as the candidate gene for the early development of PAH among Malay ASD patients. </plain></SENT>
</text></p></sec></SecTag></body><back><SecTag type="ACK_FUND"><ack><title>Acknowledgments</title><p><text4fund><text><SENT sid="132" pm="."><plain>We thank all the staffs of the National Heart Institute involved in this study for their continuous support. </plain></SENT>
<SENT sid="133" pm="."><plain>Last but not least, we also thank all the patients who participate in this study. </plain></SENT>
</text></text4fund></p></ack></SecTag><notes><title>Author Contributions</title><p>Conceptualization, V.R.; Methodology, V.R.; Validation, V.R., A.F.A.A. and G.K.; Formal Analysis, N.I.J.; Investigation, N.I.J.; Resources, V.R., P.I., A.F.A.A. and G.K.; Data Curation, N.I.J.; Writing-Original Draft Preparation, N.I.J. and V.R.; Writing-Review &amp; Editing, P.I., A.F.A.A., G.K., N.A.M., R.N.E.R.A. and V.B.; Supervision, V.R. and P.I.; Project Administration, V.R.; Funding Acquisition, P.I.</p></notes><notes><title>Funding</title><p>This research was funded by the Research University Grant Scheme (RUGS), Universiti Putra Malaysia, grant number 911440.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><SecTag type="REF"><ref-list><title>References</title><ref id="B1-jcdd-05-00048"><text><SENT sid="134" pm="."><plain>1.HumbertM.SitbonO.ChaouatA.BertocchiM.HabibG.GressinV.YaiciA.WeitzenblumE.CordierJ.F.ChabotF.Pulmonary arterial hypertension in france: Results from a national registryAm. </plain></SENT>
<SENT sid="135" pm="."><plain>J. </plain></SENT>
<SENT sid="136" pm="."><plain>Respir. </plain></SENT>
<SENT sid="137" pm="."><plain>Crit. </plain></SENT>
<SENT sid="138" pm="."><plain>Care Med.20061731023103010.1164/rccm.200510-1668OC<?supplied-pmid 16456139?>16456139 </plain></SENT>
</text></ref><ref id="B2-jcdd-05-00048"><text><SENT sid="139" pm="."><plain>2.BarstR.J.Pulmonary hypertension: Past, present and futureAnn. </plain></SENT>
<SENT sid="140" pm="."><plain>Thorac. </plain></SENT>
<SENT sid="141" pm="."><plain>Med.200831410.4103/1817-1737.37832<?supplied-pmid 19561874?>19561874 </plain></SENT>
</text></ref><ref id="B3-jcdd-05-00048"><text><SENT sid="142" pm="."><plain>3.TedfordR.J.MuddJ.O.GirgisR.E.MathaiS.C.ZaimanA.L.Housten-HarrisT.BoyceD.KelemenB.W.BacherA.C.ShahA.A.Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertensionCirc. </plain></SENT>
<SENT sid="143" pm="."><plain>Heart Fail.2013695396310.1161/CIRCHEARTFAILURE.112.000008<?supplied-pmid 23797369?>23797369 </plain></SENT>
</text></ref><ref id="B4-jcdd-05-00048"><text><SENT sid="144" pm="."><plain>4.MulderB.J.Changing demographics of pulmonary arterial hypertension in congenital heart diseaseEur. </plain></SENT>
<SENT sid="145" pm="."><plain>Respir. </plain></SENT>
<SENT sid="146" pm="."><plain>Rev.20101930831310.1183/09059180.00007910<?supplied-pmid 21119189?>21119189 </plain></SENT>
</text></ref><ref id="B5-jcdd-05-00048"><text><SENT sid="147" pm="."><plain>5.IbrahimE.KassemA.ZakariaN.The role of the biomarker and the genetic polymorphism of endothelin-1 in pulmonary arterial hypertension among egyptiansEgypt. </plain></SENT>
<SENT sid="148" pm="."><plain>J. </plain></SENT>
<SENT sid="149" pm="."><plain>Chest Dis. </plain></SENT>
<SENT sid="150" pm="."><plain>Tuberc.20126149550010.1016/j.ejcdt.2012.09.014 </plain></SENT>
</text></ref><ref id="B6-jcdd-05-00048"><text><SENT sid="151" pm="."><plain>6.JohansenA.K.DeanA.MorecroftI.HoodK.NilsenM.LoughlinL.AnagnostopoulouA.TouyzR.M.WhiteK.MacLeanM.R.The serotonin transporter promotes a pathological estrogen metabolic pathway in pulmonary hypertension via cytochrome p450 1b1Pulm. </plain></SENT>
<SENT sid="152" pm="."><plain>Circ.20166829210.1086/685023<?supplied-pmid 27162617?>27162617 </plain></SENT>
</text></ref><ref id="B7-jcdd-05-00048"><text><SENT sid="153" pm="."><plain>7.ZhangH.XuM.XiaJ.QinR.Y.Association between serotonin transporter (sert) gene polymorphism and idiopathic pulmonary arterial hypertension: A meta-analysis and review of the literatureMetab. </plain></SENT>
<SENT sid="154" pm="."><plain>Clin. </plain></SENT>
<SENT sid="155" pm="."><plain>Exp.2013621867187510.1016/j.metabol.2013.08.012<?supplied-pmid 24075737?>24075737 </plain></SENT>
</text></ref><ref id="B8-jcdd-05-00048"><text><SENT sid="156" pm="."><plain>8.HeilsA.TeufelA.PetriS.StoberG.RiedererP.BengelD.LeschK.P.Allelic variation of human serotonin transporter gene expressionJ. </plain></SENT>
<SENT sid="157" pm="."><plain>Neurochem.1996662621262410.1046/j.1471-4159.1996.66062621.x<?supplied-pmid 8632190?>8632190 </plain></SENT>
</text></ref><ref id="B9-jcdd-05-00048"><text><SENT sid="158" pm="."><plain>9.VachharajaniA.SaundersS.Allelic variation in the serotonin transporter (5HTT) gene contributes to idiopathic pulmonary hypertension in childrenBiochem. </plain></SENT>
<SENT sid="159" pm="."><plain>Biophys. </plain></SENT>
<SENT sid="160" pm="."><plain>Res. </plain></SENT>
<SENT sid="161" pm="."><plain>Commun.200533437637910.1016/j.bbrc.2005.06.107<?supplied-pmid 16009349?>16009349 </plain></SENT>
</text></ref><ref id="B10-jcdd-05-00048"><text><SENT sid="162" pm="."><plain>10.UlrichS.Szamalek-HoegelJ.HersbergerM.FischlerM.GarciaJ.S.HuberL.C.GrunigE.JanssenB.SpeichR.Sequence variants in bmpr2 and genes involved in the serotonin and nitric oxide pathways in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Relation to clinical parameters and comparison with left heart diseaseRespir. </plain></SENT>
<SENT sid="163" pm="."><plain>Int. </plain></SENT>
<SENT sid="164" pm="."><plain>Rev. </plain></SENT>
<SENT sid="165" pm="."><plain>Thorac. </plain></SENT>
<SENT sid="166" pm="."><plain>Dis.201079279287 </plain></SENT>
</text></ref><ref id="B11-jcdd-05-00048"><text><SENT sid="167" pm="."><plain>11.VadapalliS.RaniH.S.SastryB.NallariP.Endothelin-1 and endothelial nitric oxide polymorphisms in idiopathic pulmonary arterial hypertensionInt. </plain></SENT>
<SENT sid="168" pm="."><plain>J. </plain></SENT>
<SENT sid="169" pm="."><plain>Mol. </plain></SENT>
<SENT sid="170" pm="."><plain>Epidemiol. </plain></SENT>
<SENT sid="171" pm="."><plain>Genet.20101208213<?supplied-pmid 21537392?>21537392 </plain></SENT>
</text></ref><ref id="B12-jcdd-05-00048"><text><SENT sid="172" pm="."><plain>12.LuoJ.Q.WenJ.G.ZhouH.H.ChenX.P.ZhangW.Endothelial nitric oxide synthase gene g894t polymorphism and myocardial infarction: A meta-analysis of 34 studies involving 21,068 subjectsPLoS ONE20149e8719610.1371/journal.pone.0087196<?supplied-pmid 24498040?>24498040 </plain></SENT>
</text></ref><ref id="B13-jcdd-05-00048"><text><SENT sid="173" pm="."><plain>13.AlvarezR.GonzalezP.BatallaA.RegueroJ.R.Iglesias-CuberoG.HeviaS.CortinaA.MerinoE.GonzalezI.AlvarezV.Association between the nos3 (-786 t/c) and the ace (i/d) DNA genotypes and early coronary artery diseaseNitric Oxide Biol. </plain></SENT>
<SENT sid="174" pm="."><plain>Chem.2001534334810.1006/niox.2001.0351<?supplied-pmid 11485372?>11485372 </plain></SENT>
</text></ref><ref id="B14-jcdd-05-00048"><text><SENT sid="175" pm="."><plain>14.RamachandranV.IsmailP.StanslasJ.ShamsudinN.MoinS.Mohd JasR.Association of insertion/deletion polymorphism of angiotensin-converting enzyme gene with essential hypertension and type 2 diabetes mellitus in malaysian subjectsJ. </plain></SENT>
<SENT sid="176" pm="."><plain>Renin-Angiotensin-Aldost. </plain></SENT>
<SENT sid="177" pm="."><plain>Syst. </plain></SENT>
<SENT sid="178" pm="."><plain>JRAAS2008920821410.1177/1470320308097499<?supplied-pmid 19126661?>19126661 </plain></SENT>
</text></ref><ref id="B15-jcdd-05-00048"><text><SENT sid="179" pm="."><plain>15.XuG.FanG.SunY.YuL.WuS.NiuW.Association of angiotensin-converting enzyme gene i/d polymorphism with chronic obstructive pulmonary disease: A meta-analysisJ. </plain></SENT>
<SENT sid="180" pm="."><plain>Renin-Angiotensin-Aldost. </plain></SENT>
<SENT sid="181" pm="."><plain>Syst. </plain></SENT>
<SENT sid="182" pm="."><plain>JRAAS201819147032031877054610.1177/1470320318770546<?supplied-pmid 29716409?>29716409 </plain></SENT>
</text></ref><ref id="B16-jcdd-05-00048"><text><SENT sid="183" pm="."><plain>16.MlakR.Homa-MlakI.PowrozekT.MackiewiczB.MichnarM.KrawczykP.DziedzicM.RubinsztajnR.ChazanR.MilanowskiJ.Impact of i/d polymorphism of ace gene on risk of development and course of chronic obstructive pulmonary diseaseArch. </plain></SENT>
<SENT sid="184" pm="."><plain>Med. </plain></SENT>
<SENT sid="185" pm="."><plain>Sci. </plain></SENT>
<SENT sid="186" pm="."><plain>AMS20161227928710.5114/aoms.2015.50757<?supplied-pmid 27186170?>27186170 </plain></SENT>
</text></ref><ref id="B17-jcdd-05-00048"><text><SENT sid="187" pm="."><plain>17.BautistaL.E.ArdilaM.E.GamarraG.VargasC.I.ArenasI.A.Angiotensin-converting enzyme gene polymorphism and risk of myocardial infarction in colombiaMed. </plain></SENT>
<SENT sid="188" pm="."><plain>Sci. </plain></SENT>
<SENT sid="189" pm="."><plain>Monit.200410CR473CR479<?supplied-pmid 15277998?>15277998 </plain></SENT>
</text></ref><ref id="B18-jcdd-05-00048"><text><SENT sid="190" pm="."><plain>18.BahramaliE.RajabiM.JamshidiJ.MousaviS.M.ZarghamiM.ManafiA.FirouzabadiN.Association of ace gene d polymorphism with left ventricular hypertrophy in patients with diastolic heart failure: A case-control studyBMJ Open20166e01028210.1136/bmjopen-2015-010282<?supplied-pmid 26861937?>26861937 </plain></SENT>
</text></ref><ref id="B19-jcdd-05-00048"><text><SENT sid="191" pm="."><plain>19.AbrahamW.T.RaynoldsM.V.BadeschD.B.WynneK.M.GrovesB.M.RodenR.L.RobertsonA.D.LowesB.D.ZismanL.S.VoelkelN.F.Angiotensin-converting enzyme dd genotype in patients with primary pulmonary hypertension: Increased frequency and association with preserved haemodynamicsJ. </plain></SENT>
<SENT sid="192" pm="."><plain>Renin-Angiotensin-Aldost. </plain></SENT>
<SENT sid="193" pm="."><plain>Syst. </plain></SENT>
<SENT sid="194" pm="."><plain>JRAAS20034273010.3317/jraas.2003.003<?supplied-pmid 12692750?>12692750 </plain></SENT>
</text></ref><ref id="B20-jcdd-05-00048"><text><SENT sid="195" pm="."><plain>20.EddahibiS.HumbertM.FadelE.RaffestinB.DarmonM.CapronF.SimonneauG.DartevelleP.HamonM.AdnotS.Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertensionJ. </plain></SENT>
<SENT sid="196" pm="."><plain>Clin. </plain></SENT>
<SENT sid="197" pm="."><plain>Investig.20011081141115010.1172/JCI200112805<?supplied-pmid 11602621?>11602621 </plain></SENT>
</text></ref><ref id="B21-jcdd-05-00048"><text><SENT sid="198" pm="."><plain>21.GuignabertC.IzikkiM.TuL.I.LiZ.ZadigueP.Barlier-MurA.M.HanounN.RodmanD.HamonM.AdnotS.Transgenic mice overexpressing the 5-hydroxytryptamine transporter gene in smooth muscle develop pulmonary hypertensionCirc. </plain></SENT>
<SENT sid="199" pm="."><plain>Res.2006981323133010.1161/01.RES.0000222546.45372.a0<?supplied-pmid 16614302?>16614302 </plain></SENT>
</text></ref><ref id="B22-jcdd-05-00048"><text><SENT sid="200" pm="."><plain>22.WillersE.D.NewmanJ.H.LoydJ.E.RobbinsI.M.WheelerL.A.PrinceM.A.StantonK.C.CoganJ.A.RunoJ.R.ByrneD.Serotonin transporter polymorphisms in familial and idiopathic pulmonary arterial hypertensionAm. </plain></SENT>
<SENT sid="201" pm="."><plain>J. </plain></SENT>
<SENT sid="202" pm="."><plain>Respir. </plain></SENT>
<SENT sid="203" pm="."><plain>Crit. </plain></SENT>
<SENT sid="204" pm="."><plain>Care Med.200617379880210.1164/rccm.200509-1361OC<?supplied-pmid 16339917?>16339917 </plain></SENT>
</text></ref><ref id="B23-jcdd-05-00048"><text><SENT sid="205" pm="."><plain>23.MachadoR.D.KoehlerR.GlissmeyerE.VealC.SuntharalingamJ.KimM.CarlquistJ.TownM.ElliottC.G.HoeperM.Genetic association of the serotonin transporter in pulmonary arterial hypertensionAm. </plain></SENT>
<SENT sid="206" pm="."><plain>J. </plain></SENT>
<SENT sid="207" pm="."><plain>Respir. </plain></SENT>
<SENT sid="208" pm="."><plain>Crit. </plain></SENT>
<SENT sid="209" pm="."><plain>Care Med.200617379379710.1164/rccm.200509-1365OC<?supplied-pmid 16399993?>16399993 </plain></SENT>
</text></ref><ref id="B24-jcdd-05-00048"><text><SENT sid="210" pm="."><plain>24.UlasliS.S.EyubogluF.O.VerdiH.AtacF.B.Associations between endothelial nitric oxide synthase A/B, angiotensin converting enzyme I/D and serotonin transporter L/S gene polymorphisms with pulmonary hypertension in COPD patientsMol. </plain></SENT>
<SENT sid="211" pm="."><plain>Biol. </plain></SENT>
<SENT sid="212" pm="."><plain>Rep.2013405625563310.1007/s11033-013-2664-6<?supplied-pmid 24057178?>24057178 </plain></SENT>
</text></ref><ref id="B25-jcdd-05-00048"><text><SENT sid="213" pm="."><plain>25.YildizP.OflazH.CineN.Erginel-UnaltunaN.ErzenginF.YilmazV.Gene polymorphisms of endothelial nitric oxide synthase enzyme associated with pulmonary hypertension in patients with copdRespir. </plain></SENT>
<SENT sid="214" pm="."><plain>Med.2003971282128810.1016/j.rmed.2003.06.001<?supplied-pmid 14682408?>14682408 </plain></SENT>
</text></ref><ref id="B26-jcdd-05-00048"><text><SENT sid="215" pm="."><plain>26.AhsanA.RamR.BaigM.A.PashaM.A.Ace i allele and enos g allele crosstalk may have a role in chronic obstructive pulmonary diseaseClin. </plain></SENT>
<SENT sid="216" pm="."><plain>Biochem.2004371037104010.1016/j.clinbiochem.2004.05.026<?supplied-pmid 15498534?>15498534 </plain></SENT>
</text></ref><ref id="B27-jcdd-05-00048"><text><SENT sid="217" pm="."><plain>27.HoeperM.M.TacacsA.StellmacherU.LichtinghagenR.Lack of association between angiotensin converting enzyme (ace) genotype, serum ace activity, and haemodynamics in patients with primary pulmonary hypertensionHeart20038944544610.1136/heart.89.4.445<?supplied-pmid 12639879?>12639879 </plain></SENT>
</text></ref><ref id="B28-jcdd-05-00048"><text><SENT sid="218" pm="."><plain>28.TogănelR.MunteanI.DuicuC.FăgărăşanA.GozarL.BănescuC.The role of enos and agt gene polymorphisms in secondary pulmonary arterial hypertension in romanian children with congenital heart diseaseRom. </plain></SENT>
<SENT sid="219" pm="."><plain>J. </plain></SENT>
<SENT sid="220" pm="."><plain>Lab. </plain></SENT>
<SENT sid="221" pm="."><plain>Med.20132126710.2478/rrlm-2013-0031 </plain></SENT>
</text></ref><ref id="B29-jcdd-05-00048"><text><SENT sid="222" pm="."><plain>29.WangY.KikuchiS.SuzukiH.NagaseS.KoyamaA.Endothelial nitric oxide synthase gene polymorphism in intron 4 affects the progression of renal failure in non-diabetic renal diseasesNephrol. </plain></SENT>
<SENT sid="223" pm="."><plain>Dial. </plain></SENT>
<SENT sid="224" pm="."><plain>Transplant.1999142898290210.1093/ndt/14.12.2898<?supplied-pmid 10570094?>10570094 </plain></SENT>
</text></ref><ref id="B30-jcdd-05-00048"><text><SENT sid="225" pm="."><plain>30.TkacovaR.JoppaP.StancakB.SalagovicJ.MisikovaS.KalinaI.The link between angiotensin-converting enzyme genotype and pulmonary artery pressure in patients with copdWiener Klinische Wochenschrift200511721021410.1007/s00508-005-0333-z<?supplied-pmid 15875760?>15875760 </plain></SENT>
</text></ref><ref id="B31-jcdd-05-00048"><text><SENT sid="226" pm="."><plain>31.TogănelR.BănescuC.DuicuC.ŞuteuC.MunteanI.FăgărăşanA.GozarL.PascS.Angiotensin-converting enzyme gene polymorphisms in pulmonary arterial hypertension in childrenRevista Română Medicină Lab.20101831 </plain></SENT>
</text></ref><ref id="B32-jcdd-05-00048"><text><SENT sid="227" pm="."><plain>32.ShafieeS.M.FiroozraiM.SalimiS.ZandH.HesabiB.MohebbiA.Angiotensin converting enzyme dd genotype not associated with increased risk of coronary artery disease in the iranian populationPathophysiology20101716316710.1016/j.pathophys.2009.10.001<?supplied-pmid 20079615?>20079615 </plain></SENT>
</text></ref><ref id="B33-jcdd-05-00048"><text><SENT sid="228" pm="."><plain>33.SrivastavaK.NarangR.SreenivasV.DasS.DasN.Association of enos glu298asp gene polymorphism with essential hypertension in asian indiansClin. </plain></SENT>
<SENT sid="229" pm="."><plain>Chim. </plain></SENT>
<SENT sid="230" pm="."><plain>Acta2008387808310.1016/j.cca.2007.09.007<?supplied-pmid 17935708?>17935708 </plain></SENT>
</text></ref><ref id="B34-jcdd-05-00048"><text><SENT sid="231" pm="."><plain>34.UlrichS.HersbergerM.FischlerM.Nussbaumer-OchsnerY.TrederU.RussiE.W.SpeichR.Genetic polymorphisms of the serotonin transporter, but not the 2a receptor or nitric oxide synthetase, are associated with pulmonary hypertension in chronic obstructive pulmonary diseaseRespir. </plain></SENT>
<SENT sid="232" pm="."><plain>Int. </plain></SENT>
<SENT sid="233" pm="."><plain>Rev. </plain></SENT>
<SENT sid="234" pm="."><plain>Thorac. </plain></SENT>
<SENT sid="235" pm="."><plain>Dis.20107928829510.1159/000226243<?supplied-pmid 19556740?>19556740 </plain></SENT>
</text></ref><ref id="B35-jcdd-05-00048"><text><SENT sid="236" pm="."><plain>35.VasudevanR.IsmailP.JaafarN.MohamadN.EtemadE.WSW.A.EshkorS.Analysis of human bradykinin receptor gene and endothelial nitric oxide synthase gene polymorphisms in end-stage renal disease among malaysiansBalkan J. Med. </plain></SENT>
<SENT sid="238" pm="."><plain>Genet.2014173740<?supplied-pmid 25741213?>25741213 </plain></SENT>
</text></ref><ref id="B36-jcdd-05-00048"><text><SENT sid="239" pm="."><plain>36.BaloiraA.NunezM.CifrianJ.VilarinoC.OjedaM.ValverdeD.Polymorphisms in the serotonin transporter protein (sert) gene in patients with pulmonary arterial hypertensionArch. </plain></SENT>
<SENT sid="240" pm="."><plain>Bronconeumol.201248778010.1016/j.arbres.2011.10.008<?supplied-pmid 22177971?>22177971 </plain></SENT>
</text></ref><ref id="B37-jcdd-05-00048"><text><SENT sid="241" pm="."><plain>37.CaoH.GuH.QiuW.ZuoW.ZhengL.WangZ.HuZ.ChenY.Association study of serotonin transporter gene polymorphisms and ventricular septal defects related possible pulmonary arterial hypertension in chinese populationClin. </plain></SENT>
<SENT sid="242" pm="."><plain>Exp. </plain></SENT>
<SENT sid="243" pm="."><plain>Hypertens.20093160561410.3109/10641960902993061<?supplied-pmid 19886858?>19886858 </plain></SENT>
</text></ref></ref-list></SecTag></back><floats-group><SecTag type="FIG"><fig id="jcdd-05-00048-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p><text><SENT sid="244" pm="."><plain>(a) Amplification of ACE I/D in 2% agarose gel. </plain></SENT>
<SENT sid="245" pm="."><plain>DD genotype was denoted by 490 bp band (Lane 2 &amp; 3) and II genotype was shown by 190 bp band (Lane 8 &amp; 9) whereas ID genotype showed both 190 bp and 490 bp bands (Lane 5 &amp; 6). </plain></SENT>
<SENT sid="246" pm="."><plain>(b) Mistyping of ACE I/D. </plain></SENT>
<SENT sid="247" pm="."><plain>I allele showed 335 bp band (Lane 5 &amp; 6) whereas DD genotype was proven by the absence of any band (Lane 2 &amp; 3). </plain></SENT>
<SENT sid="248" pm="."><plain>(c) Restriction fragments in 4% agarose gel. </plain></SENT>
<SENT sid="249" pm="."><plain>Heterozygous type (GT genotype) showed three bands consists of 85 bp, 163 bp and 248 bp (Lane 1 &amp; 2). </plain></SENT>
<SENT sid="250" pm="."><plain>GG genotype was showed by 85 bp and 163 bp bands (Lane 3). </plain></SENT>
<SENT sid="251" pm="."><plain>Lane 4 shows the undigested 248 bp band, which was TT genotype (mutant). </plain></SENT>
<SENT sid="252" pm="."><plain>(d) PCR product of eNOS 4b/4a amplification in 2% agarose. </plain></SENT>
<SENT sid="253" pm="."><plain>Heterozygous sample (4a/b) was shown by both 393 bp and 420 bp bands (Lane 2 &amp; 3). </plain></SENT>
<SENT sid="254" pm="."><plain>Wild type (4b/b) was shown by a 420 bp band (Lane 5 &amp; 6). </plain></SENT>
<SENT sid="255" pm="."><plain>393 bp band indicated a mutant (4a/a) sample (Lane 8). </plain></SENT>
<SENT sid="256" pm="."><plain>(e) Amplification of 5-HTTLPR in 1.5% agarose gel. </plain></SENT>
<SENT sid="257" pm="."><plain>A heterozygous type (LS genotype) showed both 484 bp and 528 bp bands (Lane 2 &amp; 3). </plain></SENT>
<SENT sid="258" pm="."><plain>SS genotype was indicated by 484 b p band (Lane 5 &amp; 6) whereas LL genotype was shown by a 528 bp band (Lane 8 &amp; 9). </plain></SENT>
<SENT sid="259" pm="."><plain>M: 100-bp marker. </plain></SENT>
</text></p></caption><graphic xlink:href="jcdd-05-00048-g001"/></fig></SecTag><SecTag type="TABLE"><table-wrap id="jcdd-05-00048-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">jcdd-05-00048-t001_Table 1</object-id><label>Table 1</label><caption><p><text><SENT sid="260" pm="."><plain>Primers and PCR product for each gene polymorphisms. </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="261" pm="."><plain>Gene Polymorphisms </plain></SENT>
</text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="262" pm="."><plain>Primers </plain></SENT>
</text></th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1"><text><SENT sid="263" pm="."><plain>PCR Cycling Conditions </plain></SENT>
</text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="264" pm="."><plain>PCR Products (bp) </plain></SENT>
</text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="265" pm="."><plain>References </plain></SENT>
</text></th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="266" pm="."><plain>ACE I/D (rs4340) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="267" pm="."><plain>Forward: 5′-CTG GAG ACC ACT CCC ATC CTT TCT-3′Reverse: 5′-GAT GTG GCC ATC ACA TTC GTC ACG -AT-3′ </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="268" pm="."><plain>Denaturation Annealing Extension Final Extension Number of Cycles </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="269" pm="."><plain>95 °C, 1 min 58 °C, 2 min 72 °C, 1 min 72 °C, 2 min 30 cycles </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="270" pm="."><plain>190—DD 490—II 40 &amp; 190—ID </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="271" pm="."><plain>[20] </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="272" pm="."><plain>ACE mistyping </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="273" pm="."><plain>Forward: 5′-TGG GAC CAC AGC GCC CGC CAC TAC-3′Reverse: 5′-TCG CCA GCC CTC CCA TGC CCA TAA-3′ </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="274" pm="."><plain>Denaturation Annealing Extension Final Extension Number of Cycles </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="275" pm="."><plain>94 °C, 30 s 67 °C, 45 s 72 °C, 2 min 72 °C, 2 min 30 cycles </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="276" pm="."><plain>353—I allele no band—DD </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="277" pm="."><plain>[21] </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="278" pm="."><plain>eNOS G894T (rs1799983) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="279" pm="."><plain>Forward: 5′-AAG GCA GGA GAC AGT GGA TGG A-3′Reverse: 5′-CCC AGT CAA TCC CTT TGG TGC TCA-3′ </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="280" pm="."><plain>Denaturation Annealing Extension Final Extension Number of Cycles </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="281" pm="."><plain>94 °C, 30 s 62.8 °C, 30 s 72 °C, 2 min 72 °C, 5 min 35 cycles </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="282" pm="."><plain>248 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="283" pm="."><plain>[22] </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="284" pm="."><plain>eNOS 4b/4a </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="285" pm="."><plain>Forward: 5′-AGG CCC TAT GGT AGT GCC TTT-3′Reverse: 5′-TCT CTT AGT GCT GTG GTC AC-3′ </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="286" pm="."><plain>Denaturation Annealing Extension Final Extension Number of Cycles </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="287" pm="."><plain>94 °C, 1 min 56 °C, 1 min 72 °C, 2 min 72 °C, 7 min 35 cycles </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="288" pm="."><plain>393—4a/a 420—4b/b 393 &amp; 420—4a/b </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="289" pm="."><plain>[23] </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="290" pm="."><plain>5-HTTLPR (rs25531) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="291" pm="."><plain>Forward: 5′-GGC GTT GCC GCT CTG AAT GC-3′Reverse: 5′-GGC GTT GCC GCT CTG AAT GC-3′ </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="292" pm="."><plain>Denaturation Annealing Extension Final Extension Number of Cycles </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="293" pm="."><plain>94 °C, 30 s 61 °C, 30 s 72 °C, 1 min 72 °C, 10 min 35 cycles </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="294" pm="."><plain>528—LL 484—SS 484 &amp; 528—LS </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="295" pm="."><plain>[24] </plain></SENT>
</text></td></tr></tbody></table></table-wrap></SecTag><SecTag type="TABLE"><table-wrap id="jcdd-05-00048-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">jcdd-05-00048-t002_Table 2</object-id><label>Table 2</label><caption><p><text><SENT sid="296" pm="."><plain>Clinical characteristics of PAH patients and control subjects. </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="297" pm="."><plain>Parameter </plain></SENT>
</text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="298" pm="."><plain>Case Subjects (ASD with PAH) </plain></SENT>
</text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="299" pm="."><plain>Control Subjects (ASD without PAH) </plain></SENT>
</text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="300" pm="."><plain>p Value </plain></SENT>
</text></th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="301" pm="."><plain>Gender, M/F </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="302" pm="."><plain>2/28 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="303" pm="."><plain>6/44 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="304" pm="."><plain>- </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="305" pm="."><plain>Age </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="306" pm="."><plain>33.33 ± 9.316 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="307" pm="."><plain>37.50 ± 14.971 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="308" pm="."><plain>0.174 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="309" pm="."><plain>Age diagnosed </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="310" pm="."><plain>28.97 ± 8.838 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="311" pm="."><plain>32.80 ± 14.474 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="312" pm="."><plain>0.194 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="313" pm="."><plain>Diameter of defects (cm) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="314" pm="."><plain>3.19 ± 4.018 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="315" pm="."><plain>1.88 ± 0.852 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="316" pm="."><plain>* 0.028 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="317" pm="."><plain>MAP (mmHg) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="318" pm="."><plain>89.30 ± 12.438 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="319" pm="."><plain>78.82 ± 18.169 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="320" pm="."><plain>* 0.007 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="321" pm="."><plain>mPAP (mmHg) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="322" pm="."><plain>58.88 ± 14.53 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="323" pm="."><plain>22.04 ± 10.517 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="324" pm="."><plain>* 0.000 </plain></SENT>
</text></td></tr></tbody></table><table-wrap-foot><fn><p>PAH, pulmonary arterial hypertension; ASD, atrial septal defect; MAP, mean arterial pressure; mPAP, mean pulmonary arterial pressure. * Significant <italic>p</italic> &lt; 0.05. Values shown are mean ± SD.</p></fn></table-wrap-foot></table-wrap></SecTag><SecTag type="TABLE"><table-wrap id="jcdd-05-00048-t003" orientation="portrait" position="float"><object-id pub-id-type="pii">jcdd-05-00048-t003_Table 3</object-id><label>Table 3</label><caption><p><text><SENT sid="325" pm="."><plain>Distribution of genotypes and allele frequencies of each gene polymorphisms between PAH patients and control subjects. </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1"><text><SENT sid="326" pm="."><plain>Gene Polymorphism </plain></SENT>
</text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="327" pm="."><plain>PAH Patients (n = 30) n (%) </plain></SENT>
</text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="328" pm="."><plain>Control Subjects (n = 50) n (%) </plain></SENT>
</text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="329" pm="."><plain>p Value </plain></SENT>
</text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="330" pm="."><plain>Odds Ratio (95% Confidence Interval) </plain></SENT>
</text></th></tr></thead><tbody><tr><td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><text><SENT sid="331" pm="."><plain>ACE I/D </plain></SENT>
</text></td><td colspan="4" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="332" pm="."><plain>Genotypes </plain></SENT>
</text></td><td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><text><SENT sid="333" pm="."><plain>0.68 (0.33–1.41) </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="334" pm="."><plain>II </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="335" pm="."><plain>17 (56.67%) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="336" pm="."><plain>22 (44%) </plain></SENT>
</text></td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><text><SENT sid="337" pm="."><plain>0.53 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="338" pm="."><plain>ID </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="339" pm="."><plain>12 (40%) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="340" pm="."><plain>25 (50%) </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="341" pm="."><plain>DD </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="342" pm="."><plain>1 (3.33%) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="343" pm="."><plain>3 (6%) </plain></SENT>
</text></td></tr><tr><td colspan="4" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="344" pm="."><plain>Alleles </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="345" pm="."><plain>I </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="346" pm="."><plain>46 (76.67%) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="347" pm="."><plain>69 (69%) </plain></SENT>
</text></td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><text><SENT sid="348" pm="."><plain>0.30 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="349" pm="."><plain>D </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="350" pm="."><plain>14 (23.33%) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="351" pm="."><plain>31 (31%) </plain></SENT>
</text></td></tr><tr><td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><text><SENT sid="352" pm="."><plain>eNOS G894T </plain></SENT>
</text></td><td colspan="5" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="353" pm="."><plain>Genotypes </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="354" pm="."><plain>GG </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="355" pm="."><plain>0 (0%) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="356" pm="."><plain>1 (2%) </plain></SENT>
</text></td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><text><SENT sid="357" pm="."><plain>0.63 </plain></SENT>
</text></td><td rowspan="6" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><text><SENT sid="358" pm="."><plain>0.98 (0.51–1.85) </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="359" pm="."><plain>GT </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="360" pm="."><plain>29 (96.67%) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="361" pm="."><plain>47 (94%) </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="362" pm="."><plain>TT </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="363" pm="."><plain>1 (3.33%) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="364" pm="."><plain>2 (4%) </plain></SENT>
</text></td></tr><tr><td colspan="4" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1"><text><SENT sid="365" pm="."><plain>Alleles </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="366" pm="."><plain>G </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="367" pm="."><plain>29 (48.33%) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="368" pm="."><plain>49 (49%) </plain></SENT>
</text></td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><text><SENT sid="369" pm="."><plain>0.94 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="370" pm="."><plain>T </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="371" pm="."><plain>31 (51.67%) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="372" pm="."><plain>51 (51%) </plain></SENT>
</text></td></tr><tr><td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><text><SENT sid="373" pm="."><plain>eNOS 4b/4a </plain></SENT>
</text></td><td colspan="5" align="left" valign="middle" rowspan="1"><text><SENT sid="374" pm="."><plain>Genotypes </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1"><text><SENT sid="375" pm="."><plain>4b/b (wild type) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1"><text><SENT sid="376" pm="."><plain>21 (70%) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1"><text><SENT sid="377" pm="."><plain>35 (70%) </plain></SENT>
</text></td><td rowspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1"><text><SENT sid="378" pm="."><plain>0.57 </plain></SENT>
</text></td><td rowspan="6" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><text><SENT sid="379" pm="."><plain>1.217 (0.56–2.64) </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="380" pm="."><plain>4a/a (mutant) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="381" pm="."><plain>5 (16.7%) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="382" pm="."><plain>5 (10%) </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="383" pm="."><plain>4a/b </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="384" pm="."><plain>4 (13.3%) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="385" pm="."><plain>10 (20%) </plain></SENT>
</text></td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="386" pm="."><plain>Alleles </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="387" pm="."><plain>a </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="388" pm="."><plain>14 (23.33%) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="389" pm="."><plain>20 (20%) </plain></SENT>
</text></td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><text><SENT sid="390" pm="."><plain>0.62 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="391" pm="."><plain>b </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="392" pm="."><plain>46 (76.67%) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="393" pm="."><plain>80 (80%) </plain></SENT>
</text></td></tr><tr><td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><text><SENT sid="394" pm="."><plain>5-HTTLPR </plain></SENT>
</text></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="395" pm="."><plain>Genotypes </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><text><SENT sid="396" pm="."><plain>0.43 (0.22–0.82) </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="397" pm="."><plain>SS </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="398" pm="."><plain>6 (20%) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="399" pm="."><plain>23 (46%) </plain></SENT>
</text></td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><text><SENT sid="400" pm="."><plain>0.06 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="401" pm="."><plain>LL </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="402" pm="."><plain>12 (40%) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="403" pm="."><plain>12 (24%) </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="404" pm="."><plain>LS </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="405" pm="."><plain>12 (40%) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="406" pm="."><plain>15 (30%) </plain></SENT>
</text></td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="407" pm="."><plain>Alleles </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="408" pm="."><plain>S </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="409" pm="."><plain>24 (40%) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="410" pm="."><plain>61 (61%) </plain></SENT>
</text></td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><text><SENT sid="411" pm="."><plain>* 0.01 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="412" pm="."><plain>L </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="413" pm="."><plain>36 (60%) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="414" pm="."><plain>39 (39%) </plain></SENT>
</text></td></tr></tbody></table><table-wrap-foot><fn><p>* Value (<italic>p</italic> &lt; 0.05) was obtained using chi-square test as compared with controls. Data are reported as number of subjects, with percent in parentheses.</p></fn></table-wrap-foot></table-wrap></SecTag><SecTag type="TABLE"><table-wrap id="jcdd-05-00048-t004" orientation="portrait" position="float"><object-id pub-id-type="pii">jcdd-05-00048-t004_Table 4</object-id><label>Table 4</label><caption><p><text><SENT sid="415" pm="."><plain>Distribution between polymorphisms and clinical characteristics of the subjects. </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="416" pm="."><plain>Gene Polymorphism </plain></SENT>
</text></th><th colspan="4" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1"><text><SENT sid="417" pm="."><plain>ASD with PAH (Case) </plain></SENT>
</text></th><th colspan="4" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1"><text><SENT sid="418" pm="."><plain>ASD without PAH (Control) </plain></SENT>
</text></th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="419" pm="."><plain>Age * </plain></SENT>
</text></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="420" pm="."><plain>Size of Defect * </plain></SENT>
</text></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="421" pm="."><plain>MAP *(mmHg) </plain></SENT>
</text></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="422" pm="."><plain>mPAP * (mmHg) </plain></SENT>
</text></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="423" pm="."><plain>Age * </plain></SENT>
</text></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="424" pm="."><plain>Size of Defect * </plain></SENT>
</text></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="425" pm="."><plain>MAP * (mmHg) </plain></SENT>
</text></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="426" pm="."><plain>mPAP * (mmHg) </plain></SENT>
</text></th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="427" pm="."><plain>ACE I/D </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="428" pm="."><plain>II </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="429" pm="."><plain>32.71 ± 9.51 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="430" pm="."><plain>2.59 ± 0.88 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="431" pm="."><plain>90.71 ± 10.51 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="432" pm="."><plain>59.09 ± 17.53 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="433" pm="."><plain>36.95 ± 13.54 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="434" pm="."><plain>2.18 ± 0.77 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="435" pm="."><plain>72.86 ± 23.51 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="436" pm="."><plain>24.23 ± 12.59 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="437" pm="."><plain>ID </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="438" pm="."><plain>34.42 ± 9.75 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="439" pm="."><plain>4.29 ± 6.23 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="440" pm="."><plain>87.25 ± 15.48 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="441" pm="."><plain>58.92 ± 10.40 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="442" pm="."><plain>39.64 ± 16.03 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="443" pm="."><plain>1.66 ± 0.83 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="444" pm="."><plain>84.20 ± 10.79 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="445" pm="."><plain>20.64 ± 8.58 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="446" pm="."><plain>DD </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="447" pm="."><plain>31.00 ± 0.00 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="448" pm="."><plain>0.22 ± 0.00 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="449" pm="."><plain>90.00 ± 0.00 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="450" pm="."><plain>55.00 ± 0.00 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="451" pm="."><plain>23.67 ± 11.59 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="452" pm="."><plain>1.44 ± 1.24 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="453" pm="."><plain>77.67 ± 11.68 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="454" pm="."><plain>17.67 ± 7.64 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="455" pm="."><plain>eNOS G894T </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="456" pm="."><plain>GG </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="457" pm="."><plain>- </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="458" pm="."><plain>- </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="459" pm="."><plain>- </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="460" pm="."><plain>- </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="461" pm="."><plain>29.00 ± 0.00 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="462" pm="."><plain>1.96 ± 0.00 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="463" pm="."><plain>77.00 ± 0.00 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="464" pm="."><plain>17.00 ± 0.00 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="465" pm="."><plain>GT </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="466" pm="."><plain>32.66 ± 8.69 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="467" pm="."><plain>3.22 ± 4.09 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="468" pm="."><plain>89.10 ± 12.61 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="469" pm="."><plain>58.98 ± 14.77 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="470" pm="."><plain>38.07 ± 15.48 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="471" pm="."><plain>1.91 ± 0.85 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="472" pm="."><plain>78.54 ± 18.90 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="473" pm="."><plain>35.11 ± 21.98 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="474" pm="."><plain>TT </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="475" pm="."><plain>53.00 ± 0.00 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="476" pm="."><plain>2.30 ± 0.00 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="477" pm="."><plain>95.00 ± 0.00 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="478" pm="."><plain>56.00 ± 0.00 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="479" pm="."><plain>31.67 ± 1.53 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="480" pm="."><plain>1.27 ± 0.90 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="481" pm="."><plain>83.67 ± 4.04 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="482" pm="."><plain>35.75 ± 17.21 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="483" pm="."><plain>eNOS 4b/4a </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="484" pm="."><plain>4b/b </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="485" pm="."><plain>35.48 ± 9.82 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="486" pm="."><plain>3.60 ± 4.45 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="487" pm="."><plain>89.29 ± 13.17 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="488" pm="."><plain>58.07 ± 14.23 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="489" pm="."><plain>38.37 ± 16.24 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="490" pm="."><plain>1.94 ± 0.87 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="491" pm="."><plain>78.91 ± 11.78 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="492" pm="."><plain>21.69 ± 9.40 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="493" pm="."><plain>4a/b </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="494" pm="."><plain>27.50 ± 8.43 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="495" pm="."><plain>3.75 ± 3.59 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="496" pm="."><plain>93.25 ± 15.15 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="497" pm="."><plain>71.50 ± 13.48 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="498" pm="."><plain>36.90 ± 13.34 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="499" pm="."><plain>1.85 ± 0.82 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="500" pm="."><plain>78.50 ± 24.29 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="501" pm="."><plain>26.70 ± 14.47 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="502" pm="."><plain>4a/a </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="503" pm="."><plain>29.00 ± 3.54 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="504" pm="."><plain>1.05 ± 1.23 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="505" pm="."><plain>86.20 ± 7.40 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="506" pm="."><plain>52.20 ± 12.76 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="507" pm="."><plain>32.60 ± 8.17 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="508" pm="."><plain>1.47 ± 0.82 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="509" pm="."><plain>78.70 ± 5.40 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="510" pm="."><plain>15.20 ± 4.32 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="511" pm="."><plain>5-HTTLPR </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="512" pm="."><plain>SS </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="513" pm="."><plain>36.00 ± 9.80 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="514" pm="."><plain>2.77 ± 0.77 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="515" pm="."><plain>93.33 ± 8.60 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="516" pm="."><plain>52.67 ± 11.38 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="517" pm="."><plain>38.52 ± 15.73 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="518" pm="."><plain>1.87 ± 0.87 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="519" pm="."><plain>78.35 ± 20.18 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="520" pm="."><plain>22.65 ± 11.27 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="521" pm="."><plain>LS </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="522" pm="."><plain>33.50 ± 10.71 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="523" pm="."><plain>4.57 ± 6.12 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="524" pm="."><plain>88.08 ± 11.57 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="525" pm="."><plain>59.08 ± 17.05 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="526" pm="."><plain>40.13 ± 14.82 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="527" pm="."><plain>1.98 ± 0.71 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="528" pm="."><plain>78.87 ± 19.70 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="529" pm="."><plain>22.20 ± 10.52 </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="530" pm="."><plain>LL </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="531" pm="."><plain>31.83 ± 8.01 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="532" pm="."><plain>2.04 ± 1.09 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="533" pm="."><plain>88.50 ± 15.14 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="534" pm="."><plain>61.79 ± 13.28 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="535" pm="."><plain>32.25 ± 13.51 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="536" pm="."><plain>1.76 ± 1.02 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="537" pm="."><plain>79.66 ± 12.70 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="538" pm="."><plain>20.67 ± 11.45 </plain></SENT>
</text></td></tr></tbody></table><table-wrap-foot><fn><p>Values are mean ± SD. * = not significant (<italic>p</italic> &gt; 0.05).</p></fn></table-wrap-foot></table-wrap></SecTag><SecTag type="TABLE"><table-wrap id="jcdd-05-00048-t005" orientation="portrait" position="float"><object-id pub-id-type="pii">jcdd-05-00048-t005_Table 5</object-id><label>Table 5</label><caption><p><text><SENT sid="539" pm="."><plain>Genotypes and allele frequency distribution. </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="540" pm="."><plain>Population </plain></SENT>
</text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="541" pm="."><plain>Disease </plain></SENT>
</text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="542" pm="."><plain>No </plain></SENT>
</text></th><th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1"><text><SENT sid="543" pm="."><plain>Genotypes (%) </plain></SENT>
</text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text></text></th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1"><text><SENT sid="544" pm="."><plain>Allele (%) </plain></SENT>
</text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text></text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="545" pm="."><plain>Study </plain></SENT>
</text></th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="546" pm="."><plain>ACE I/D </plain></SENT>
</text></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="547" pm="."><plain>II </plain></SENT>
</text></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="548" pm="."><plain>ID </plain></SENT>
</text></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="549" pm="."><plain>DD </plain></SENT>
</text></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="550" pm="."><plain>p Value </plain></SENT>
</text></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="551" pm="."><plain>I </plain></SENT>
</text></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="552" pm="."><plain>D </plain></SENT>
</text></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="553" pm="."><plain>p Value </plain></SENT>
</text></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="554" pm="."><plain>Malaysia </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="555" pm="."><plain>HPT </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="556" pm="."><plain>65 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="557" pm="."><plain>36.9 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="558" pm="."><plain>52.3 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="559" pm="."><plain>10.8 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="560" pm="."><plain>* </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="561" pm="."><plain>63.08 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="562" pm="."><plain>36.92 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="563" pm="."><plain>** </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="564" pm="."><plain>[14] </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="565" pm="."><plain>USA </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="566" pm="."><plain>PPH </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="567" pm="."><plain>60 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="568" pm="."><plain>45 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="569" pm="."><plain>35 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="570" pm="."><plain>20 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="571" pm="."><plain>** </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="572" pm="."><plain>- </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="573" pm="."><plain>- </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="574" pm="."><plain>- </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="575" pm="."><plain>[19] </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="576" pm="."><plain>Caucasian </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="577" pm="."><plain>COPD </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="578" pm="."><plain>66 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="579" pm="."><plain>22.73 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="580" pm="."><plain>46.97 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="581" pm="."><plain>30.3 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="582" pm="."><plain>* </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="583" pm="."><plain>- </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="584" pm="."><plain>- </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="585" pm="."><plain>- </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="586" pm="."><plain>[30] </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="587" pm="."><plain>Romania </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="588" pm="."><plain>PAH </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="589" pm="."><plain>29 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="590" pm="."><plain>6.90 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="591" pm="."><plain>58.62 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="592" pm="."><plain>34.48 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="593" pm="."><plain>* </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="594" pm="."><plain>39.58 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="595" pm="."><plain>60.42 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="596" pm="."><plain>* </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="597" pm="."><plain>[31] </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="598" pm="."><plain>German </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="599" pm="."><plain>PPH </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="600" pm="."><plain>51 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="601" pm="."><plain>9.8 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="602" pm="."><plain>58.82 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="603" pm="."><plain>31.37 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="604" pm="."><plain>NS </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="605" pm="."><plain>- </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="606" pm="."><plain>- </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="607" pm="."><plain>- </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="608" pm="."><plain>[27] </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="609" pm="."><plain>Iran </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="610" pm="."><plain>CAD </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="611" pm="."><plain>224 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="612" pm="."><plain>12.5 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="613" pm="."><plain>38.84 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="614" pm="."><plain>48.66 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="615" pm="."><plain>NS </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="616" pm="."><plain>31.92 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="617" pm="."><plain>68.08 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="618" pm="."><plain>NS </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="619" pm="."><plain>[32] </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="620" pm="."><plain>Malaysia </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="621" pm="."><plain>PAH </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="622" pm="."><plain>30 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="623" pm="."><plain>56.67 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="624" pm="."><plain>40.0 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="625" pm="."><plain>3.33 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="626" pm="."><plain>NS </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="627" pm="."><plain>76.67 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="628" pm="."><plain>23.33 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="629" pm="."><plain>NS </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="630" pm="."><plain>Current study </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="631" pm="."><plain>eNOS G894T </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="632" pm="."><plain>GG </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="633" pm="."><plain>GT </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="634" pm="."><plain>TT </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="635" pm="."><plain>G </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="636" pm="."><plain>T </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="637" pm="."><plain>Germany </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="638" pm="."><plain>IPAH </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="639" pm="."><plain>16 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="640" pm="."><plain>27 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="641" pm="."><plain>53 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="642" pm="."><plain>20 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="643" pm="."><plain>NS </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="644" pm="."><plain>53 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="645" pm="."><plain>47 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="646" pm="."><plain>NS </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="647" pm="."><plain>[10] </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="648" pm="."><plain>India </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="649" pm="."><plain>IPAH </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="650" pm="."><plain>77 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="651" pm="."><plain>50.65 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="652" pm="."><plain>41.16 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="653" pm="."><plain>51.95 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="654" pm="."><plain>NS </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="655" pm="."><plain>72.73 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="656" pm="."><plain>27.27 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="657" pm="."><plain>NS </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="658" pm="."><plain>[11] </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="659" pm="."><plain>India </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="660" pm="."><plain>EH </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="661" pm="."><plain>226 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="662" pm="."><plain>139 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="663" pm="."><plain>82 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="664" pm="."><plain>5 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="665" pm="."><plain>*** </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="666" pm="."><plain>79.65 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="667" pm="."><plain>20.35 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="668" pm="."><plain>*** </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="669" pm="."><plain>[33] </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="670" pm="."><plain>Malaysia </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="671" pm="."><plain>PAH </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="672" pm="."><plain>30 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="673" pm="."><plain>0 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="674" pm="."><plain>96.67 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="675" pm="."><plain>3.33 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="676" pm="."><plain>NS </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="677" pm="."><plain>48.33 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="678" pm="."><plain>51.67 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="679" pm="."><plain>NS </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="680" pm="."><plain>Current study </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="681" pm="."><plain>eNOS 4b/4a </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="682" pm="."><plain>bb </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="683" pm="."><plain>ab </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="684" pm="."><plain>Aa </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="685" pm="."><plain>p </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="686" pm="."><plain>a </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="687" pm="."><plain>b </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="688" pm="."><plain>Germany </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="689" pm="."><plain>IPAH </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="690" pm="."><plain>16 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="691" pm="."><plain>67 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="692" pm="."><plain>33 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="693" pm="."><plain>- </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="694" pm="."><plain>NS </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="695" pm="."><plain>83 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="696" pm="."><plain>17 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="697" pm="."><plain>NS </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="698" pm="."><plain>[10] </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="699" pm="."><plain>Turkey </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="700" pm="."><plain>PH in COPD </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="701" pm="."><plain>24 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="702" pm="."><plain>83 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="703" pm="."><plain>17 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="704" pm="."><plain>0 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="705" pm="."><plain>* </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="706" pm="."><plain>8.33 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="707" pm="."><plain>91.67 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="708" pm="."><plain>- </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="709" pm="."><plain>[25] </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="710" pm="."><plain>Swiss </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="711" pm="."><plain>PH in COPD </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="712" pm="."><plain>27 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="713" pm="."><plain>63 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="714" pm="."><plain>33 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="715" pm="."><plain>4 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="716" pm="."><plain>NS </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="717" pm="."><plain>20.37 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="718" pm="."><plain>79.63 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="719" pm="."><plain>- </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="720" pm="."><plain>[34] </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="721" pm="."><plain>Malaysia </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="722" pm="."><plain>ESRD </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="723" pm="."><plain>150 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="724" pm="."><plain>87.33 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="725" pm="."><plain>11.33 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="726" pm="."><plain>1.33 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="727" pm="."><plain>NS </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="728" pm="."><plain>93 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="729" pm="."><plain>7 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="730" pm="."><plain>NS </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="731" pm="."><plain>[35] </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="732" pm="."><plain>Malaysia </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="733" pm="."><plain>PAH </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="734" pm="."><plain>30 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="735" pm="."><plain>70 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="736" pm="."><plain>16.67 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="737" pm="."><plain>13.33 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="738" pm="."><plain>NS </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="739" pm="."><plain>23.33 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="740" pm="."><plain>58.78 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="741" pm="."><plain>NS </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="742" pm="."><plain>Current study </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="743" pm="."><plain>5-HTTLPR </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="744" pm="."><plain>SS </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="745" pm="."><plain>LS </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="746" pm="."><plain>LL </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="747" pm="."><plain>p </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="748" pm="."><plain>S </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="749" pm="."><plain>L </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="750" pm="."><plain>Caucasian </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="751" pm="."><plain>IPAH </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="752" pm="."><plain>11 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="753" pm="."><plain>81.82 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="754" pm="."><plain>0 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="755" pm="."><plain>18.18 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="756" pm="."><plain>* </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="757" pm="."><plain>18.18 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="758" pm="."><plain>81.82 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="759" pm="."><plain>- </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="760" pm="."><plain>[9] </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="761" pm="."><plain>Germany </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="762" pm="."><plain>COPD + PAH </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="763" pm="."><plain>27 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="764" pm="."><plain>18.52 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="765" pm="."><plain>59.26 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="766" pm="."><plain>22.22 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="767" pm="."><plain>- </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="768" pm="."><plain>51.85 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="769" pm="."><plain>48.15 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="770" pm="."><plain>* </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="771" pm="."><plain>[10] </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="772" pm="."><plain>Spain </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="773" pm="."><plain>IPAH + 2° PAH </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="774" pm="."><plain>49 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="775" pm="."><plain>26.53 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="776" pm="."><plain>28.15 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="777" pm="."><plain>20.41 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="778" pm="."><plain>NS </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="779" pm="."><plain>46.94 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="780" pm="."><plain>53.06 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="781" pm="."><plain>- </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="782" pm="."><plain>[36] </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="783" pm="."><plain>Chinese </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="784" pm="."><plain>VSD-related PAH </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="785" pm="."><plain>140 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="786" pm="."><plain>50.71 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="787" pm="."><plain>36.43 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="788" pm="."><plain>12.86 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="789" pm="."><plain>* </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="790" pm="."><plain>31.07 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="791" pm="."><plain>68.93 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="792" pm="."><plain>- </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="793" pm="."><plain>[37] </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="794" pm="."><plain>Malaysia </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="795" pm="."><plain>PAH </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="796" pm="."><plain>30 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="797" pm="."><plain>20 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="798" pm="."><plain>40 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="799" pm="."><plain>40 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="800" pm="."><plain>NS </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="801" pm="."><plain>40 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="802" pm="."><plain>60 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="803" pm="."><plain>* </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="804" pm="."><plain>Current study </plain></SENT>
</text></td></tr></tbody></table><table-wrap-foot><fn><p>HPT, hypertension; PPH, primary pulmonary hypertension; COPD, cardiac obstructive pulmonary disease; PAH, pulmonary arterial hypertension; CAD, coronary artery disease; EH, essential hypertension; ESRD, end stage renal disease; IPAH, idiopathic pulmonary arterial hypertension; VSD, ventricular septal defect * (<italic>p</italic> &lt; 0.05), ** (<italic>p</italic> &lt; 0.01), *** (<italic>p</italic> &lt; 0.001), at 5% level of significance, NS: not significant (<italic>p</italic> &gt; 0.05).</p></fn></table-wrap-foot></table-wrap></SecTag></floats-group></article>
